Ray Therapeutics
Pioneering vision restoration therapies for severe retinal degenerations.
About
Ray Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies to restore vision for individuals suffering from severe retinal degenerations. Their approach aims to address unmet medical needs in ophthalmology. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Ray Therapeutics do?
Ray Therapeutics is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Healthcare, Medical Devices. It is based in Berkeley, California, USA and was founded in 2021. Public records show $243M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Ray Therapeutics raised?
Ray Therapeutics has raised a total of $243M in funding. The most recent round on record is Series B.
Where is Ray Therapeutics headquartered?
Ray Therapeutics is headquartered in Berkeley, California, USA.
When was Ray Therapeutics founded?
Ray Therapeutics was founded in 2021.
What industry does Ray Therapeutics operate in?
Ray Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Medical Devices, Biotech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.